Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: A randomized, open-label, two-period, cross-over trial.
Papa
Giuseppe
G
Division of Internal Medicine, University of Catania, Italy.
Fedele
Viviana
V
Rizzo
Maria Rosaria
MR
Fioravanti
Marisa
M
Leotta
Carmelo
C
Solerte
Sebastiano Bruno
SB
Purrello
Francesco
F
Paolisso
Giuseppe
G
D000368:Aged; D002219:Carbamates / Q000009:adverse effects / Q000627:therapeutic use*; D018592:Cross-Over Studies; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005905:Glyburide / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*
D002219:Carbamates; D010880:Piperidines; C072379:repaglinide; D005905:Glyburide